[Skip to Navigation]
October 1984

Betaxolol and Timolol-Reply

Author Affiliations

Durham, NC
Portland, Ore

Arch Ophthalmol. 1984;102(10):1424-1426. doi:10.1001/archopht.1984.01040031154004

In Reply.  —We appreciate Dr Harrison's interest in our article and are pleased to respond to the important questions that he has raised.Harrison thinks that our patients did not represent a random sample of eyes with IOP, since they were selected from a glaucoma clinic and the majority were already receiving timolol. The subjects were indeed selected according to specific criteria, by virtue of which they were being followed up in our glaucoma clinics. The patients were not selected on the basis of prior glaucoma therapy, and we too were concerned by the large number receiving timolol, as we discussed in our article. However, since a substantial majority of glaucoma patients in the United States are currently receiving timolol, our study group is felt to be representative of the glaucoma population in this country.We agree with Dr Harrison that a study involving only the test drugs would be

Add or change institution